Active DNA demethylation is upstream of rod-photoreceptor fate determination and required for retinal development.

Saved in:
Bibliographic Details
Title: Active DNA demethylation is upstream of rod-photoreceptor fate determination and required for retinal development.
Authors: Hernández-Núñez I; John F. Hardesty, MD Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO, USA., Urman A; Center for Pharmacogenetics, Washington University School of Medicine, St. Louis, MO, USA., Zhang X; John F. Hardesty, MD Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO, USA., Jacobs W; Center for Pharmacogenetics, Washington University School of Medicine, St. Louis, MO, USA., Hoffman C; John F. Hardesty, MD Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO, USA., Rebba S; John F. Hardesty, MD Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO, USA., Harding EG; John F. Hardesty, MD Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO, USA., Li Q; Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan, Ann Arbor, MI, USA., Mao F; Department of Pathology, University of Michigan, Ann Arbor, MI, USA., Cani AK; Division of Hematology and Oncology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.; Rogel Cancer Center, University of Michigan, Ann Arbor, MI, United States., Chen S; John F. Hardesty, MD Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO, USA.; Department of Developmental Biology, Washington University School of Medicine, St. Louis, MO, USA., Dawlaty MM; Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research, Department of Genetics, and Department of Developmental & Molecular Biology, Albert Einstein College of Medicine, Bronx, NY, USA., Rao RC; Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan, Ann Arbor, MI, USA.; Department of Pathology, University of Michigan, Ann Arbor, MI, USA.; Department and Center of Computational Medicine and Bioinformatics, Comprehensive Cancer Center, A. Alfred Taubman Medical Research Institute, Center for RNA Biomedicine, Department of Human Genetics, University of Michigan, Ann Arbor, MI, USA.; Division of Ophthalmology, Surgery Section, VA Ann Arbor Health System, Ann Arbor, MI, USA., Ruzycki PA; John F. Hardesty, MD Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO, USA., Edwards JR; Center for Pharmacogenetics, Washington University School of Medicine, St. Louis, MO, USA.; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA., Clark BS; John F. Hardesty, MD Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO, USA.; Department of Developmental Biology, Washington University School of Medicine, St. Louis, MO, USA.
Source: BioRxiv : the preprint server for biology [bioRxiv] 2025 Feb 03. Date of Electronic Publication: 2025 Feb 03.
Publication Type: Journal Article; Preprint
Journal Info: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2692-8205
DOI:10.1101/2025.02.03.636318